Novavax has shared positive preliminary results from a real-world study of its JN.1-adapted COVID-19 vaccine. The SHIELD-Utah ...

The CDC is considering recommending annual COVID-19 shots to those who are older or who have compromised immune function, ...

A federal website that used to feature information on vaccines, testing and treatment for COVID-19 has been transformed.

One of the FDA’s recently departed top officials is weighing in on the wide-ranging staff cuts at the agency and how they ...

Trump administration cuts across federal health agencies have sent shivers through a biotech industry already struggling ...

For meningococcal vaccines, ACIP recommended that GSK's pentavalent vaccine (Penmenvy), designed to protect against A, B, C, ...

The advisory committee, which met Tuesday for the first time since Robert F. Kennedy Jr. was sworn in as health secretary, ...

An advisory panel on vaccines meets, carefully, in the shadow of a health secretary who has often criticized it.

在国际关系和公共卫生领域，一场前所未有的风暴正在酝酿。Novavax，这家曾被视为疫苗界希望之星的企业，如今却陷入了前所未有的困境。这一切，都源于新任卫生与公众服务部（HHS）部长小罗伯特·肯尼迪的一番言论。 Novavax疫苗从未有效？ 4月1日，原本是Novavax新冠疫苗获得FDA全面批准的日子。然而，由于新任局长的“异常”干预，FDA首次错过了其PDUFA。这一事件本身已经不同寻常，但更令 ...

肯尼迪的这番评论似乎与临床数据背道而驰。此前临床数据显示，Novavax的疫苗疗效不输于mRNA疫苗，其疫苗预防所有新冠肺炎感染总体保护率为90.4％，针对重症疾病的有效性为100％。

04/15 14:33 关注新茶饮行业趋势，了解各品牌产品上新信息。  来自北京市 只有继续“搏”，才有可能成为真正的巨头。 小罗伯特·肯尼迪出任卫生与公众服务部（HHS）部长后，市场对于疫苗产业的担忧终于化作现实。 当他对媒体宣称“Novavax的疫苗单一抗原方法从未对呼吸系统疾病有效”后，这家老牌疫苗企业的股价瞬间暴跌近20%。 在外界看来，这不仅是单一企业的危机，甚至可能会成为美国疫苗监管体 ...